Skip to main content
NewslettersWatchlist

Zoetis Inc Cl A(ZTS-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low169.64
Day High174.28
Open:172.59
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
Zoetis (ZTS) Q3 2024 Earnings Call Transcript
Stock Target Advisor
Zoetis Inc Delivers on Q3 2024 Results: What It Means for the Future of ZTS Stock
Barchart
3 Defensive Dividend Stocks to Protect Against Pre-Election Volatility
Newswire.ca
Sustainable Agriculture: The Growing Need for Biotech Innovations in the World's Food Supplies
BayStreet.ca
Innovative Agritech Solutions Powering the Future of Sustainable Agriculture
Barchart
Stocks Stabilize and Recover Some of Monday’s Slump
Motley Fool
Zoetis (ZTS) Q2 2024 Earnings Call Transcript
Motley Fool
Why Zoetis Stock Was Moving Higher Tuesday
Barchart
Stocks Climb as Dip Buyers Emerge After Monday’s Plunge
Barchart
3 Top-Rated Healthcare Stocks With 20% to 35% Upside Potential
Barchart
3 'Strong Buy' Value Stocks to Buy and Hold
Motley Fool
Beat the Dow Jones With This Cash-Gushing Dividend Stock
Motley Fool
4 Oversold Stocks to Buy Right Now
TheNewswire.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Barchart
5 High-Quality Stock Picks from Goldman Sachs
Motley Fool
Zoetis (ZTS) Q1 2024 Earnings Call Transcript
Motley Fool
Why Zoetis Stock Popped by Almost 6% on Thursday
TheNewswire.com
ZTS LOSS ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Barchart
Options Watchlist: 10 Stocks Showing High IV Percentile
Motley Fool
1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation
TheNewswire.com
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
TheNewswire.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS

Profile

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.